Location History:
- München, DE (2013)
- Munich, DE (2013 - 2024)
Company Filing History:
4 out of 88 
2 out of 3,923 
1 out of 12 Years Active: 2013-2024
Title: Tanja Herrmann: Pioneering Inventor in Munich
Introduction:
Tanja Herrmann is a renowned inventor based in Munich, Germany, who has contributed significantly to the fields of immunology and biotechnology. With a strong background in research and development, Herrmann's innovative work has led to several groundbreaking patents in the area of antibody generation and treatment of various diseases.
Latest Patents:
1. Antibodies specific for human complement C5A receptor (C5AR): Herrmann's invention presents novel antibodies or antibody fragments that target the human C5aR, offering potential applications in the treatment of inflammatory, autoimmune diseases, and cancer.
2. Method for generating antibodies against T cell receptor: Herrmann's patented method outlines a structured approach to generating antibodies that bind to cell surface proteins of interest, thereby opening new doors for targeted therapies in the medical realm.
Career Highlights:
Herrmann has made significant contributions to leading biotechnology companies such as MorphoSys AG and Novartis AG. His expertise and innovative mindset have propelled groundbreaking research and development efforts, making him a key figure in the field of biopharmaceuticals.
Collaborations:
Throughout his career, Herrmann has collaborated closely with esteemed colleagues such as Stefanie Urlinger and Markus Enzelberger. Together, they have fostered a culture of innovation and excellence, leading to the successful development of cutting-edge technologies in the realm of immunotherapy.
Conclusion:
Tanja Herrmann's prolific career as an inventor and researcher showcases his unwavering commitment to advancing science and improving healthcare outcomes. His groundbreaking patents and collaborative efforts underscore his dedication to making a lasting impact in the fields of immunology and biotechnology.